Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HerinCAR-PD1 cells in advanced solid tumors
NCT02862028Phase 2Unknown
- Sponsor
- Shanghai International Medical Center
- Start
- Aug 2016
- Primary completion
- Mar 2018
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of HerinCAR-PD1 cells in lung cancer, liver cancer, gastric cancer (GC), sponsored by Shanghai International Medical Center. Status: unknown.
02
Drugs
HerinCAR-PD1 cells
03
Conditions
lung cancerliver cancergastric cancer (GC)
Beyond the preview
Go deeper on NCT02862028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02862028.